29.9 C
New York
Friday, June 5, 2026

Tag: pharmacies

Greenberg Traurig Expands Health Care & FDA Capabilities in California with Addition of Deborah J. Rotenberg and Team

SACRAMENTO, Calif., June 5, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, LLP continues the growth of its Health Care & FDA Practice with the...

Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories

Cosmos Health launches Oliv18™, a USDA and EU certified whole olive polyphenol supplement targeting cardiovascular and antioxidant categories.

Disclosure of transparency notification from FMR LLC

Regulated information
Nazareth (Belgium)/Rotterdam (The Netherlands), 3 June 2026 – 6 PM CET

Demand for Compounding Pharmacies in USA to Reach USD 12.79 Billion by 2036 Amid Growing Need for Personalized Therapies and Specialized Medication Solutions

NEWARK, Del., June 2, 2026 /PRNewswire/ -- The Demand for Compounding Pharmacies in USA is projected to grow from USD 6.04 billion in 2026 to...

Affirmed Housing, VTA Break Ground on 195-Home Affordable Housing Community at Berryessa BART Station

Construction has started on RISE, a 195-unit affordable housing development adjacent to the Berryessa/North San José BART Station.

Kroger Health, along with Hy-Vee, Convenes Industry Leaders to Shape the Future of Health at Nourishing Change Conference

As chronic disease, GLP-1 adoption, and food for health reshape American healthcare, Kroger Health gathers leaders to explore the grocery store's emerging role as...

Cocamidopropyl Betaine (CAPB) Market Size to Reach USD 1.45 Billion by 2033, Driven by Growing Demand for Mild Surfactant Systems, Regulatory-Aligned Formulations, and Expanding...

Verified Market Research® Reports Rising Adoption Across Personal Care, Household Cleaning, Industrial Cleaning, and Agrochemical Formulations as Manufacturers Prioritize Foam Stability, Cleansing Performance, Formulation...

Cocamidopropyl Betaine (CAPB) Market Size to Reach USD 1.45 Billion by 2033, Driven by Growing Demand for Mild Surfactant Systems, Regulatory-Aligned Formulations, and Expanding...

Verified Market Research® Reports Rising Adoption Across Personal Care, Household Cleaning, Industrial Cleaning, and Agrochemical Formulations as Manufacturers Prioritize Foam Stability, Cleansing Performance, Formulation...

Hydreight Delivers Record First Quarter 2026 Revenue of $24.9 Million with 449% Revenue Growth, $3.3 Million in Adjusted EBITDA² and $32.0 Million in Working...

Revenue increased 449% year-over-year while the Company continued to scale its healthcare infrastructure platform. VANCOUVER, BC and LAS VEGAS, June 1, 2026 /CNW/ - Hydreight...

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Hims To Contact Him Directly To Discuss Their Options

Public health notice: Outbreak of Salmonella infections linked to various brands of pistachios and pistachio-containing products

August 15, 2025: Update OTTAWA, ON, Aug. 15, 2025 /CNW/ - This outbreak investigation is ongoing. The public health notice will be updated as the investigation...

Navamedic ASA: National approvals of Flexilev® in OraFID® granted across all Nordic countries

OSLO, Norway, Aug. 13, 2025 /PRNewswire/ -- Navamedic is pleased to announce that it has received final approval for the packaging material in national...

HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000...

NEW YORK and NEW ORLEANS, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 25, 2025 to file lead plaintiff applications in securities class action lawsuits against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS), if they purchased the Company’s securities between April 29, 2025 and June 23, 2025, inclusive (the “Class Period”). These actions are pending in the United States District Court for the Northern District of California.

/R E P E A T — METRO Inc. to Release 2025 Third Quarter Results/

MONTREAL, July 14, 2025 /CNW/ - METRO Inc. will release its third quarter fiscal 2025 results on August 13, 2025. The release will be...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPharmacies